Ligand validation:2GSM

TRD: TRIDECANE

TRD is a Ligand Of Interest in 2GSM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2GSM_TRD_A_5007	41%	85%	0.15	0.862	0.22	0.51	-	-	2	0	100%	1
2GSM_TRD_A_5006	40%	81%	0.137	0.847	0.28	0.54	-	-	2	0	100%	1
2GSM_TRD_C_6010	36%	83%	0.128	0.877	0.31	0.47	-	-	0	0	69%	0.6923
2GSM_TRD_D_6008	31%	88%	0.139	0.888	0.25	0.41	-	-	0	0	54%	0.5385
2GSM_TRD_B_5008	28%	84%	0.133	0.84	0.27	0.48	-	-	2	0	69%	0.6923
2GSM_TRD_A_5005	28%	79%	0.149	0.797	0.28	0.57	-	-	2	0	100%	1
2GSM_TRD_D_6007	21%	79%	0.19	0.797	0.24	0.62	-	-	0	0	100%	1
2GSM_TRD_A_5010	12%	80%	0.206	0.729	0.27	0.56	-	-	0	0	100%	1
2GSM_TRD_C_6006	10%	78%	0.173	0.681	0.27	0.61	-	-	1	0	100%	1
2GSM_TRD_A_5009	10%	86%	0.19	0.772	0.32	0.39	-	-	0	0	54%	0.5385
2GSM_TRD_C_6009	6%	83%	0.185	0.662	0.3	0.48	-	-	0	0	69%	0.6923
2GSM_TRD_C_6001	5%	81%	0.232	0.644	0.31	0.51	-	-	1	0	100%	1
6PW0_TRD_D_303	43%	75%	0.148	0.927	0.12	0.85	-	-	0	0	69%	0.6923
6PW1_TRD_D_301	42%	76%	0.141	0.913	0.12	0.81	-	-	0	0	69%	0.6923
3OM3_TRD_C_3	28%	82%	0.226	0.878	0.27	0.53	-	-	1	0	100%	1
6CI0_TRD_D_303	26%	78%	0.203	0.899	0.1	0.77	-	-	2	0	69%	0.6923
4ZR1_TRD_A_410	49%	75%	0.18	0.926	0.12	0.84	-	-	1	0	100%	1
6LPK_TRD_A_2422	41%	98%	0.14	0.853	0.14	0.14	-	-	0	0	100%	1
6LPJ_TRD_A_2422	38%	98%	0.154	0.855	0.13	0.16	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.